Common Contracts

9 similar null contracts by AEON Biopharma, Inc., Graf Acquisition Corp. IV, Priveterra Acquisition Corp., others

The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, WNNR and Target on the Trade Date specified below. The term “Counterparty” refers to WNNR...
Andretti Acquisition Corp. • March 26th, 2024 • Services-prepackaged software

This Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, WNNR and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

AutoNDA by SimpleDocs
The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller and HNRA on the Trade Date specified below. The term “Counterparty” refers to HNRA. In...
HNR Acquisition Corp. • November 3rd, 2023 • Crude petroleum & natural gas

This Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller and HNRA as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, GFOR and Target on the Trade Date specified below. The term “Counterparty” refers to GFOR...
Graf Acquisition Corp. IV • September 29th, 2023 • Biological products, (no disgnostic substances)

This Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, GFOR and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, GFOR and Target on the Trade Date specified below. The term “Counterparty” refers to GFOR...
Graf Acquisition Corp. IV • September 29th, 2023 • Biological products, (no disgnostic substances)

This Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, GFOR and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, OXAC and Target on the Trade Date specified below. The term “Counterparty” refers to OXAC...
Oxbridge Acquisition Corp. • August 7th, 2023 • Air transportation, nonscheduled

This Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, OXAC and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, Priveterra and Target on the Trade Date specified below. The term “Counterparty” refers to...
AEON Biopharma, Inc. • July 27th, 2023 • Pharmaceutical preparations

This Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, Priveterra and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, Priveterra and Target on the Trade Date specified below. The term “Counterparty” refers to...
AEON Biopharma, Inc. • July 27th, 2023 • Pharmaceutical preparations

This Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, Priveterra and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, Priveterra and Target on the Trade Date specified below. The term “Counterparty” refers to...
Priveterra Acquisition Corp. • June 30th, 2023 • Pharmaceutical preparations

This Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, Priveterra and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, Priveterra and Target on the Trade Date specified below. The term “Counterparty” refers to...
Priveterra Acquisition Corp. • June 30th, 2023 • Pharmaceutical preparations

This Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, Priveterra and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.

Time is Money Join Law Insider Premium to draft better contracts faster.